The Second Act: Why Sexual Fulfillment Often Peaks After 60
For decades, cultural tropes have painted a bleak picture of aging: the idea that sexual vitality is a finite resource that inevitably dwindles as we approach our later years. Society…
For decades, cultural tropes have painted a bleak picture of aging: the idea that sexual vitality is a finite resource that inevitably dwindles as we approach our later years. Society…
As record-breaking heat waves become an increasingly frequent hallmark of the American summer, many people are bracing for the usual seasonal concerns: heat exhaustion, sunburn, and dehydration. However, medical experts…
During her pregnancy with her son, Milan, Monique Rodriguez, founder of Mielle Organics, experienced a sensation that was both familiar and terrifying. As a former labor and delivery nurse, she…
For decades, the medical community and the general public have operated under a specific, narrow archetype: the middle-aged, overweight man who snores loudly and gasps for air in his sleep.…
For generations, the narrative surrounding the unmarried woman has been one of deficiency. From the dismissive tropes of the "spinster" and the "old maid" to the modern, politically charged label…
The quest for eternal youth has transitioned from the realm of alchemy and folklore into the sterile, high-tech laboratories of modern longevity science. For decades, researchers have hunted for a…
For millions of people, the arrival of spring is not merely marked by the blooming of flowers and the return of warmer weather—it is marked by the onset of a…
In the digital age, few biological processes are as misunderstood—or as aggressively marketed—as metabolism. Across social media platforms, influencers frequently promise that a "sluggish" metabolism can be "revved up" or…
In the polished, filtered world of social media, a specific brand of domestic influencer has risen to prominence by championing an extreme form of "from-scratch" living. These creators document themselves…
For millions of Americans living with obesity and type 2 diabetes, the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists—marketed as Ozempic, Wegovy, Zepbound, and Mounjaro—has been nothing short of a…